Blog Entries for DrVasilev

MonaVie Acai Berry Primary and Recurrent Cancer Prevention

svasilev@gyndoctor.com — Thu, 21 Aug 2008 17:53:21 +0100

If there ever was a miracle food substance with far reaching disease prevention potential it is the Acai Berry from Brazil. You may have been reading a lot of hooplah about it as an anti-oxidant "par-excellance". Well, that hooplah is well deserved in cancer prevention.... BOTH primary and recurrence prevention. The anti-oxidant properties of the acai berry is off the charts, and the MonaVie blend of super-berries actually has scientific research under its belt. A k [...]

Imiquimod: Effective for Vulvar Dysplasia

svasilev@gyndoctor.com — Fri, 04 Apr 2008 02:00:00 +0100

A common treatment for vulvar pre-malignant conditions is surgery, which can be disfiguring and painful. Alternatives to surgery have long been sought but none have been effective and easy to use. Investigators at several Netherlands institutions, reporting in this week's New England Journal of Medicine, looked at the effectiveness of imiquimod 5% cream, a topical immune-response modulator, for the treatment of this condition.

Fifty-two patients with grade 2 or 3 vulvar intraepithelial [...]

Clear Cell Ovarian Cancer: Worse Prognosis?

svasilev@gyndoctor.com — Mon, 24 Mar 2008 23:57:58 +0100

Dr. Teoh and colleagues from UCSF, Stanford and UCI reviewed the SEER database between 1988 and 2001 to try to answer this question. The National Cancer Institute's SEER, Surveillance Epidemiology and End Results, is the largest registry of data available and compiles data from all reporting tumor registries from hospitals nationwide. Their review was presented at the latest Society of Gynecologic Oncologists meeting this month in Tampa Florida.

During the period reviewed [...]

Ovarian Cancer: Is Chemotherapy Dose Important?

svasilev@gyndoctor.com — Mon, 24 Mar 2008 02:00:00 +0100

According to a study presented at the Society of Gynecologic Oncologists March 2008 meeting in Tampa, chemotherapy dose reduction is associated with poor survival in advanced ovarian cancer. This is not shocking new information, but is a reminder that there is indeed a need to balance aggressive treatment with quality of life.

Dr. Chura and associates looked at those patients who had to have their doses of chemotherapy either reduced or delayed for medical reasons. These reasons w [...]